Cargando…
miRNA engineering of CHO cells facilitates production of difficult‐to‐express proteins and increases success in cell line development
In recent years, coherent with growing biologics portfolios also the number of complex and thus difficult‐to‐express (DTE) therapeutic proteins has increased considerably. DTE proteins challenge bioprocess development and can include various therapeutic protein formats such as monoclonal antibodies...
Autores principales: | Fischer, Simon, Marquart, Kim F., Pieper, Lisa A., Fieder, Juergen, Gamer, Martin, Gorr, Ingo, Schulz, Patrick, Bradl, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084326/ https://www.ncbi.nlm.nih.gov/pubmed/28262952 http://dx.doi.org/10.1002/bit.26280 |
Ejemplares similares
-
Structural analysis of random transgene integration in CHO manufacturing cell lines by targeted sequencing
por: Stadermann, Anna, et al.
Publicado: (2022) -
Engineering CHO cell growth by stable manipulation of miRNA expression
por: Sanchez, Noëlia, et al.
Publicado: (2011) -
Generation of genetically engineered CHO cell lines to support the production of a difficult to express therapeutic protein
por: Laux, Holger, et al.
Publicado: (2013) -
Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology
por: Stepper, Lisa, et al.
Publicado: (2020) -
Engineering CHO cell metabolism for growth in galactose
por: Jiménez, Natalia E, et al.
Publicado: (2011)